- Home
- SPAI vs OSTX Comparison
SPAI vs OSTX Comparison
Compare SPAI & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPAI
- OSTX
- Stock Information
- Founded
- SPAI 2021
- OSTX 2018
- Country
- SPAI United States
- OSTX United States
- Employees
- SPAI N/A
- OSTX N/A
- Industry
- SPAI Industrial Specialties
- OSTX
- Sector
- SPAI Health Care
- OSTX
- Exchange
- SPAI Nasdaq
- OSTX NYSE
- Market Cap
- SPAI 38.5M
- OSTX 43.0M
- IPO Year
- SPAI 2024
- OSTX 2024
- Fundamental
- Price
- SPAI $3.52
- OSTX $1.68
- Analyst Decision
- SPAI
- OSTX Strong Buy
- Analyst Count
- SPAI 0
- OSTX 3
- Target Price
- SPAI N/A
- OSTX $18.00
- AVG Volume (30 Days)
- SPAI 38.6K
- OSTX 725.8K
- Earning Date
- SPAI 08-15-2025
- OSTX 08-14-2025
- Dividend Yield
- SPAI N/A
- OSTX N/A
- EPS Growth
- SPAI N/A
- OSTX N/A
- EPS
- SPAI N/A
- OSTX N/A
- Revenue
- SPAI $2,046,327.00
- OSTX N/A
- Revenue This Year
- SPAI N/A
- OSTX N/A
- Revenue Next Year
- SPAI N/A
- OSTX N/A
- P/E Ratio
- SPAI N/A
- OSTX N/A
- Revenue Growth
- SPAI 140.22
- OSTX N/A
- 52 Week Low
- SPAI $1.47
- OSTX $1.12
- 52 Week High
- SPAI $6.50
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- SPAI N/A
- OSTX N/A
- Support Level
- SPAI N/A
- OSTX N/A
- Resistance Level
- SPAI N/A
- OSTX N/A
- Average True Range (ATR)
- SPAI 0.00
- OSTX 0.00
- MACD
- SPAI 0.00
- OSTX 0.00
- Stochastic Oscillator
- SPAI 0.00
- OSTX 0.00
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.